CS21 AND LNGA PROTEIN VACCINES

摘要

A vaccine composition including an LngA peptide or a fragment or variant thereof and a pharmaceutically acceptable carrier is described. The vaccine composition can be administered to prevent or inhibit an enterotoxigenic Escherichia coli infection in a subject.